- 関
- cytogenesis
WordNet
- the origin and development and variation of cells (同)cytogeny
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Allogeneic hematopoietic SCT in combination with tyrosine kinase inhibitor treatment compared with TKI treatment alone in CML blast crisis.
- Jiang H1, Xu LP1, Liu DH1, Liu KY1, Chen SS1, Jiang B1, Jiang Q1, Chen H1, Chen YH1, Han W1, Zhang XH1, Wang Y1, Wang JZ1, Wang FR1, Qin YZ1, Lai YY1, Huang XJ2.
- Bone marrow transplantation.Bone Marrow Transplant.2014 Jul 21. doi: 10.1038/bmt.2014.146. [Epub ahead of print]
- CML treatment with tyrosine kinase inhibitors (TKIs) has improved many patients' prognosis, but during the disease's terminal phase, the blast crisis (CML-BC), has been disappointing. Allo-HSCT is another treatment, but survival rates are still disappointing. Currently, a combination of these two is
- PMID 25046218
- Establishment of Human cell Type-Specific iPS cells with Enhanced Chondrogenic Potential.
- Guzzo RM1, Scanlon V, Sanjay A, Xu RH, Drissi H.
- Stem cell reviews.Stem Cell Rev.2014 Jun 25. [Epub ahead of print]
- The propensity of induced pluripotent stem (iPS) cells to differentiate into specific lineages may be influenced by a number of factors, including the selection of the somatic cell type used for reprogramming. Herein we report the generation of new iPS cells, which we derived from human articular ch
- PMID 24958240
- Electron microscopic features of brain edema in rodent cerebral malaria in relation to glial fibrillary acidic protein expression.
- Ampawong S1, Chaisri U1, Viriyavejakul P1, Nontprasert A2, Grau GE3, Pongponratn E1.
- International journal of clinical and experimental pathology.Int J Clin Exp Pathol.2014 Apr 15;7(5):2056-67. eCollection 2014.
- The mechanisms leading to cerebral malaria (CM) are not completely understood. Brain edema has been suggested as having an important role in experimental CM. In this study, CBA/CaH mice were infected with Plasmodium berghei ANKA blood-stage and when typical symptoms of CM developed on day 7, brain t
- PMID 24966914
Japanese Journal
- シンビジウムのPLB由来の小植物体およびEC由来のPLB・小植物体における細胞遺伝学的分析
- TEIXEIRA DA SILVA J. A.,田中 道男
- 園芸学会雑誌. 別冊, 園芸学会大会研究発表 74(1), 462, 2005-03-20
- NAID 10024387353
- 分子標的薬, メシル酸イマチニブ(グリベック^<【○!R】>)の薬理学的特性および臨床効果
- 都賀 稚香,近藤 翠,所 明男
- 日本薬理学雑誌 121(2), 119-128, 2003-02-01
- メシル酸イマチニブ(グリベック®)は,分子標的コンセプトに基づきノバルティス ファーマ社で合成·開発された慢性骨髄性白血病(CML)治療薬である.CMLの発症本態であるBcr-Ablチロシンキナーゼを標的とし,その活性を阻害することで細胞内シグナル伝達を抑え,CML細胞の細胞増殖を抑制することが示された.キナーゼアッセイおよび細胞レベルでのチロシンキナーゼ自己リン酸化における検討から,メシル酸イマ …
- NAID 130000086209
Related Links
- cytogenic [si″to-jen´ik] 1. pertaining to cytogenesis. 2. forming or producing cells. cy·to·gen·ic (sī'tō-jen'ik), Relating to cytogenesis. cytogenic /cy·to·gen·ic/ (si-to-jen´ik) 1. pertaining to cytogenesis. 2. forming or producing cells.
- cytogenetic [si″to-jĕ-net´ik] 1. chromosomal. 2. pertaining to cytogenetics. cytogenetic technologist a clinical laboratory scientist who carries out diagnostic testing, including culturing, harvesting, staining, photomicroscopy, and ...
★リンクテーブル★
[★]
- 関
- cytogenic
[★]
- 英
- cytogenesis、cytogenic